Home LiteratureArticle Details
PMID: 8594241 Published · ppublish English Journal Article Multicenter Study Research Support, Non-U.S. Gov't

Neonatal characteristics in rapidly progressive perinatally acquired HIV-1 disease. The French Pediatric HIV Infection Study Group.

JAMA ·Vol. 275 ·No. 8 ·1996-02-28 ·Pages 606-10

Mayaux MJ, Burgard M, Teglas JP, Cottalorda J, Krivine A, Simon F, Puel J, Tamalet C, Dormont D, Masquelier B, Doussin A, Rouzioux C, Blanche S

Abstract

To identify clinical and laboratory parameters at birth that are associated with the rapidly progressive form of human immunodeficiency virus type 1 (HIV-1) disease in children born to infected mothers. Multicenter, prospective study of infants born to HIV-seropositive mothers. A total of 62 obstetric and pediatric centers in France. Of 1386 children born to HIV-1-seropositive mothers at least 18 months before the cutoff date, 267 were infected. Infection was defined as serological positivity at 18 months or death from HIV disease before the age. Category C events (including opportunistic infections, recurrent severe bacterial infections, cancers, specific encephalopathy, and wasting syndrome) in the new pediatric Centers for Disease Control and Prevention classification during the first year of life, according to clinical, immunological, and virological findings at birth. The risk of category C manifestations at 12 months was significantly higher when an infected newborn had liver and/or spleen enlargement and/or adenopathies (38.1% vs 15.1%; relative risk [RR], 2.5; 95% confidence interval [CI], 1.4 to 6.0; P<.02) or a low proportion (<30%) of CD4+ cells at birth (45.5% vs 15.0%; RR, 3.0; 95% CI, 1.4 to 6.4; P<.005). Similarly, HIV-1 culture and/or polymerase chain reaction positivity during the first week of life was associated with a higher risk of the early, severe form of HIV infection (26.4% vs 9.3%; RR, 2.8; 95% CI, 1.3 to 6.1; P<.006). In case of positive antigenemia at birth, the risk was 50.0% vs 14.4% (RR, 3.5; 95% CI, 1.9 to 6.2; P<.001). These parameters, determined at birth, were strongly interrelated and could reflect active disease onset in utero in some cases of early, severe HIV-1 disease in childhood. These prognostic markers, particularly virological parameters, are of value in monitoring children infected by HIV and might serve as a basis for early therapeutic intervention.

MeSH Terms
AIDS Serodiagnosis/methods Disease Progression Female HIV Infections/congenital,diagnosis,physiopathology,transmission HIV Seropositivity/congenital,diagnosis,physiopathology,transmission HIV-1/isolation & purification Humans Infant Infant, Newborn Infectious Disease Transmission, Vertical Polymerase Chain Reaction Pregnancy Pregnancy Complications, Infectious/virology Prognosis Prospective Studies Severity of Illness Index Survival Analysis
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Mayaux M J
Institut National de la Santé et de la Recherche Médicale, Hôpital Bicêtre, Le Kremlin-Bicêtre, France.
Burgard M
Teglas J P
Cottalorda J
Krivine A
Simon F
Puel J
Tamalet C
Dormont D
Masquelier B
Doussin A
Rouzioux C
Blanche S
Article Info
Journal
JAMA
Abbr.
JAMA
ISSN
0098-7484
Published
1996-02-28
Pages
606-10
Language
English
Region
United States
NLM ID
7501160
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com